219 related articles for article (PubMed ID: 36018488)
1. Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with
Yao F; Bian S; Zhu D; Yuan Y; Pan K; Pan Z; Feng X; Tang K; Yang Y
Radiol Med; 2022 Oct; 127(10):1170-1178. PubMed ID: 36018488
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Machine learning-based analysis of [
Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
[TBL] [Abstract][Full Text] [Related]
4. Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.
Luining WI; Oprea-Lager DE; Vis AN; van Moorselaar RJA; Knol RJJ; Wondergem M; Boellaard R; Cysouw MCF
PLoS One; 2023; 18(11):e0293672. PubMed ID: 37943772
[TBL] [Abstract][Full Text] [Related]
5. Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on
Yi Z; Hu S; Lin X; Zou Q; Zou M; Zhang Z; Xu L; Jiang N; Zhang Y
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1523-1534. PubMed ID: 34845536
[TBL] [Abstract][Full Text] [Related]
6. Multimodal radiomics based on 18F-Prostate-specific membrane antigen-1007 PET/CT and multiparametric MRI for prostate cancer extracapsular extension prediction.
Pan K; Yao F; Hong W; Xiao J; Bian S; Zhu D; Yuan Y; Zhang Y; Zhuang Y; Yang Y
Br J Radiol; 2024 Feb; 97(1154):408-414. PubMed ID: 38308032
[TBL] [Abstract][Full Text] [Related]
7. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [
Papp L; Spielvogel CP; Grubmüller B; Grahovac M; Krajnc D; Ecsedi B; Sareshgi RAM; Mohamad D; Hamboeck M; Rausch I; Mitterhauser M; Wadsak W; Haug AR; Kenner L; Mazal P; Susani M; Hartenbach S; Baltzer P; Helbich TH; Kramer G; Shariat SF; Beyer T; Hartenbach M; Hacker M
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1795-1805. PubMed ID: 33341915
[TBL] [Abstract][Full Text] [Related]
8. Establishment and prospective validation of an SUV
Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
[No Abstract] [Full Text] [Related]
9. Diagnostic performance of
Rahbar K; Afshar-Oromieh A; Seifert R; Wagner S; Schäfers M; Bögemann M; Weckesser M
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2055-2061. PubMed ID: 30027419
[TBL] [Abstract][Full Text] [Related]
10.
Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of
Liu X; Wang Q; Zhang B; Jiang T; Zeng W
Hell J Nucl Med; 2022; 25(1):88-102. PubMed ID: 35388806
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of integrated
Zeng Y; Leng X; Liao H; Jiang G; Chen P
Prostate Int; 2022 Jun; 10(2):108-116. PubMed ID: 35510079
[TBL] [Abstract][Full Text] [Related]
13. [
Xie Y; Li C; Zhang L; Zang S; Yu F; Wang S; Wang F
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1143-1148. PubMed ID: 36073212
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Validation of PSMA Expression Measured by
Woythal N; Arsenic R; Kempkensteffen C; Miller K; Janssen JC; Huang K; Makowski MR; Brenner W; Prasad V
J Nucl Med; 2018 Feb; 59(2):238-243. PubMed ID: 28775203
[No Abstract] [Full Text] [Related]
15. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
[TBL] [Abstract][Full Text] [Related]
16. Head-to-Head Comparison of
Kuten J; Fahoum I; Savin Z; Shamni O; Gitstein G; Hershkovitz D; Mabjeesh NJ; Yossepowitch O; Mishani E; Even-Sapir E
J Nucl Med; 2020 Apr; 61(4):527-532. PubMed ID: 31562225
[No Abstract] [Full Text] [Related]
17. Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in
Zamboglou C; Bettermann AS; Gratzke C; Mix M; Ruf J; Kiefer S; Jilg CA; Benndorf M; Spohn S; Fassbender TF; Bronsert P; Chen M; Guo H; Wang F; Qiu X; Grosu AL
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1987-1997. PubMed ID: 33210239
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer.
Wang Z; Li Y; Zheng A; Gao J; Yuan W; Shen C; Bai L; Duan X
Front Oncol; 2022; 12():1018833. PubMed ID: 36457489
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
20. Role of radiomic analysis of [
Marturano F; Guglielmo P; Bettinelli A; Zattoni F; Novara G; Zorz A; Sepulcri M; Gregianin M; Paiusco M; Evangelista L
Eur Radiol; 2023 Oct; 33(10):7199-7208. PubMed ID: 37079030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
